Oleg Nodelman, Director at Kindred Biosciences, Inc. (KIN), bought 47,000 shares at $10.70 ($510K) on 2014-08-27, disclosed to the SEC on 2014-08-29.
Open-market purchase of $510k KIN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.70 | 9,927 | $106K | 20.8% |
| 2 | $10.70 | 12,073 | $129K | 25.3% |
| 3 | $10.98 | 11,280 | $124K | 24.3% |
| 4 | $10.98 | 13,720 | $151K | 29.5% |
| Total | $10.85 avg | 47,000 | $510K | 100% |
| Filing → |
| ZYME | BUY | 2025-03-13 | $26.2M | — | Filing → |
| NUVB | BUY | 2023-09-21 | $6.7M | — | Filing → |
| ANAB | BUY | 2021-05-04 | $5.1M | — | Filing → |